PortfoliosStock ScreensStocksStockXcel

Strides Pharma Science Limited

STAR | BSE

511.60

INR

26.30

5.42%

STAR | BSE

About Strides Pharma Science Limited

Sector

Healthcare

Industry

Drug Manufacturers-Specialty & Generic

Earnings date

30/09/2023

As of date

08/12/2023

Close

511.60

Open

486.20

High

514.55

Low

486.20

Strides Pharma Science Limited develops manufactures and sells pharmaceutical products in Africa Australia North America Europe Asia India and internationally. It operates through two segments Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms such as tablets hard and soft gelatin capsules sachets and liquids as well as nasal spray powders solids ointments and creams. It also develops branded generics products for the treatment of chronic therapies including women's health central nervous system cardiovascular diabetes dermatology and probiotics under the Renerve Unibrol Combiart Duotab and Vitafer brands; and anti-retroviral anti-malarial anti-tuberculosis Hepatitis and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop manufacture and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru India.

View Less

STAR | BSE

Risk
28.0%
Sharpe
1.47
Luna's Score
67/100
Recommendation
Buy

Luna says (STAR | BSE)

What's Working

Positive Momentum

Strength based on increasing price with high volume

Low Market Beta (-0.4 to 0.8)

Value Stock (Price to Book < 3)

Strong Revenue Growth (> 10%)

Strong Sharpe Ratio (> 1.2)

What's not Working

Smallcap (300M - 2B USD)

High Debt to Equity (> 0.75)

Weak Operating Margin (< 10%)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

10 days

36.3%

1 month

28.0%

3 months

37.2%

6 months

38.0%

Return

Fundamental Ratios

PE

0

Fwd. PE

0

Price to book

2.17

Debt to equity

1.36

Debt to assets

0.44

Ent. to EBITDA

27.31

Ent. to rev.

1.85

PEG

0

Other Fundamentals

EBITDA

5.02B

MarketCap

46.98B

MarketCap(USD)

563.27M

Div. yield

0.30

Op. margin

9.31

Erngs. growth

-36.80

Rev. growth

11.40

Ret. on equity

-11.86

Short ratio

0

Short perc.

0

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bullish (SMA6M > SMA12M)

SMAs: Stock Price Trends

Range10D

40.50

Range1M

50.00

Range3M

96.25

Volumes: Market Activity

Rel. volume

1.78

Price X volume

16.94M

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007